Richard F. Ambinder
Johns Hopkins University
H-index: 94
North America-United States
Top articles of Richard F. Ambinder
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Efficacy of single-agent chemotherapy with pegylated liposomal doxorubicin or gemcitabine in a diverse cohort of patients with recalcitrant cutaneous T-cell lymphoma | British Journal of Dermatology | David Weiner Andrew Ly Sai Talluru Ananya Munjal Olivia Pierog | 2024/3 |
Impact of Prophylactic Trimethoprim-Sulfamethoxazole on Clearance of High-Dose Methotrexate in Adult Patients | JCO Oncology Practice | Daniel Skoloda Matthew Newman Haval Norman Jamie E Ziggas Richard F Ambinder | 2024/2 |
Nelfinavir Inhibition of Kaposi’s sarcoma-associated herpesvirus protein expression and capsid assembly | Infectious Agents and Cancer | Maggie Li Barbara J Smith Jaeyeun Lee Jennifer Petr Nicole M Anders | 2024/12 |
Sir Michael Anthony Epstein (1921–2024) | Science | Richard F Ambinder Rena R Xian | 2024/4/19 |
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study | Cancer | Lakshmi Rajdev Chia‐Ching Jackie Wang Himanshu Joshi Shelly Lensing Jeannette Lee | 2024/3/15 |
Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age≥ 55 Years | Transplantation and cellular therapy | Jonathan A Webster Madison Reed Hua-Ling Tsai Alexander Ambinder Tania Jain | 2023/3/1 |
A Phase I Trial of Activated Donor-Derived Marrow Infiltrating Lymphocytes to Treat Relapsed Hematologic Malignancies after Allogeneic Transplantation with Post-Transplantation … | Blood | Joseph Rimando Francesco Mazziotta Alison Gareau Maria Bettinotti Jonathan Allen Webster | 2023/11/28 |
DARATUMUMAB AND EPOCH FOR HIV+/‐PLASMABLASTIC LYMPHOMA: A FEASIBILITY STUDY OF THE AIDS MALIGNANCY CONSORTIUM (AMC 105) | Hematological Oncology | A Noy SK Barta CR Tan D Kwon R Baiocchi | 2023/6 |
Three-year outcomes in recipients of mismatched unrelated bone marrow donor transplants using post-transplantation cyclophosphamide: Follow-up from a National Marrow Donor … | Transplantation and Cellular Therapy | Bronwen E Shaw Antonio Martin Jimenez-Jimenez Linda J Burns Brent R Logan Farhad Khimani | 2023/3/1 |
Barriers to HIV-associated lymphoma diagnosis in Soweto, South Africa: A nurse's perspective. | Gugulethu Tshabalala Nomathemba Tshabalala Neil Martinson Richard F Ambinder Janan Dietrich | 2023/6/1 | |
Results from an Intergroup Randomized Phase II Study of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Classic Hodgkin … | Blood | Catherine S Diefenbach Opeyemi Jegede Stephen M Ansell Christian Steidl Yasodha Natkunam | 2023/11/28 |
Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma | Blood | Nicole Thomas Kostiantyn Dreval Daniela S Gerhard Laura K Hilton Jeremy S Abramson | 2023/2/23 |
549 Clinical features and risk factors of cutaneous eruptions after stem cell transplantation | Journal of Investigative Dermatology | V Madan J Blum D Weiner O Pierog P Imus | 2023/5/1 |
Cell-Free Circulating Tumor DNA and Epstein-Barr Virus DNA for Early Diagnosis of Epstein-Barr Virus–Associated Cancers | Journal of Clinical Oncology | Rena R Xian Richard F Ambinder | 2023/9/10 |
Phase I trial of the multi-kinase inhibitor cabozantinib, a CYP3A4 substrate, plus CYP3A4-interacting antiretroviral therapy in people living with HIV and cancer (AMC-087) | Clinical Cancer Research | Missak Haigentz Jr Jeannette Y Lee Elizabeth Y Chiao David M Aboulafia Lee Ratner | 2023/12/15 |
A novel tumor suppressor encoded by a 1p36. 3 lncRNA functions as a phosphoinositide-binding protein repressing AKT phosphorylation/activation and promoting autophagy | Cell Death & Differentiation | Lili Li Xing-sheng Shu Hua Geng Jianming Ying Lei Guo | 2023/5 |
Brentuximab vedotin with AVD for stage II–IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial | The Lancet Haematology | Paul G Rubinstein Page C Moore Milan Bimali Jeanette Y Lee Michelle A Rudek | 2023/8/1 |
Could Active TB be a Major Contributor to the Disparity in Presentation and Mortality for cHL in HIV+ and HIV-Individuals in South Africa? | Blood | Samantha L Vogt Nomathemba Tshabalala Neil A Martinson Wendy Stevens Philippa Ashmore | 2023/11/28 |
Allogeneic blood or marrow transplantation with post-transplantation cyclophosphamide for peripheral T cell lymphoma: the importance of graft source | Cole H Sterling Michael S Hughes Hua-Ling Tsai Kathryn Yarkony Ephraim J Fuchs | 2023/4/1 | |
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia | Blood, The Journal of the American Society of Hematology | Amy E DeZern Marianna Zahurak Heather J Symons Kenneth R Cooke Carol Ann Huff | 2023/6/22 |
